In the phase 2 randomised controlled trial (Jastreboff et al., New England Journal of Medicine , 2023), participants receiving higher doses of retatrutide achieved mean weight reductions of up to 17.5% of body weight over 24 weeks, with greater losses reported at 48 weeks
We know many of you have been waiting patiently to access CareCore, and honestly, we are just as eager to get this into your hands as you are to use it
Timing Considerations When Taking Semaglutide Blood donation requires adequate hydration, stable blood pressure, and a hemoglobin level above a minimum threshold
Will I regain weight if I stop taking a GLP-1 drug
Researchers screened 70 hypothyroid patients on tirzepatide, ultimately analyzing 17 who met strict criteria, including stable levothyroxine doses before starting tirzepatide and adequate follow-up data
Published on May 21st, 2025